HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Post by sbmanon Jan 28, 2014 4:48pm

390 Views

Post# 22144293

Greenblatt's Value Investors Club has write-up of Automod

It puts the value per share on a sum of the parts basis as between 2.75 and 3.58. The post was written six weeks ago but is only now available to non-club members:

https://www.valueinvestorsclub.com/value2/Idea/ViewIdea/110939

You'll have to register but this is not a spam site.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario